Get complete Patent Opposition Report for Biontech Cell & Gene Therapies

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Biontech Cell & Gene Therapies against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3170842Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use ThereofCAFA THERAPEUTICSJun 4, 2020